<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0255562</journal-id>
      <journal-id journal-id-type="nlm-ta">N Engl J Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">N Engl J Med</journal-id>
      <journal-title-group>
        <journal-title>The New England journal of medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-4793</issn>
      <issn pub-type="epub">1533-4406</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34161705</article-id>
      <article-id pub-id-type="pmc">7611730</article-id>
      <article-id pub-id-type="manuscript">EMS133246</article-id>
      <article-id pub-id-type="doi">10.1056/NEJMoa1915722</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Collier</surname>
            <given-names>Jack J.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A1">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guissart</surname>
            <given-names>Claire</given-names>
          </name>
          <degrees>Pharm.D.</degrees>
          <aff id="A2" xml:lang="fr">Institut Universitaire de Recherche Clinique and Laboratoire de G&#xE9;n&#xE9;tique Mol&#xE9;culaire, University of Montpellier and Centre Hospitalier Universitaire (CHU) de Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ol&#xE1;hov&#xE1;</surname>
            <given-names>Monika</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A3">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sasorith</surname>
            <given-names>Souphatta</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A4" xml:lang="fr">Institut Universitaire de Recherche Clinique and Laboratoire de G&#xE9;n&#xE9;tique Mol&#xE9;culaire, University of Montpellier and Centre Hospitalier Universitaire (CHU) de Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piron-Prunier</surname>
            <given-names>Florence</given-names>
          </name>
          <degrees>M.Sc.</degrees>
          <aff id="A5">Montpellier, and the Institute for Integrative Biology of the Cell (I2BC), Universit&#xE9; Paris-Saclay, Alternative Energies and Atomic Energy Commission (CEA), CNRS Gif-sur-Yvette, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suomi</surname>
            <given-names>Fumi</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A6">Translational Stem Cell Biology and Metabolism Program, Research Programs Unit, and the Department of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>David</given-names>
          </name>
          <degrees>M.Sc.</degrees>
          <aff id="A7">Newcastle University, Newcastle Upon Tyne, and the Institute of Child Health, Department of Molecular Neuroscience, University College London Institute of Neurology, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martinez-Lopez</surname>
            <given-names>Nuria</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A8">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Radiation Oncology, Albert Einstein College of Medicine, New York</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leboucq</surname>
            <given-names>Nicolas</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A9">Departments of Neuroradiology, France</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bahr</surname>
            <given-names>Angela</given-names>
          </name>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azzarello-Burri</surname>
            <given-names>Silvia</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <aff id="A10">Institute of Medical Genetics, University of Zurich, Zurich, Switzerland</aff>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Reich</surname>
            <given-names>Selina</given-names>
          </name>
          <degrees>M.Sc.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sch&#xF6;ls</surname>
            <given-names>Ludger</given-names>
          </name>
          <degrees>M.D.</degrees>
        </contrib>
        <aff id="A11">Hertie Institute for Clinical Brain Research and Center of Neurology, and the German Center for Neurodegenerative Diseases, University of T&#xFC;bingen, T&#xFC;bingen, Germany</aff>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Polvikoski</surname>
            <given-names>Tuomo M.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A12">Translational and Clinical Research Institute, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>Pierre</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A13">Pediatric Neurology, France; Reference Center for Neuromuscular Diseases Atlantic&#x2013;Occitania&#x2013;Caribbean (AOC), France, CHU de Montpellier, and Laboratoire de Physiologie et M&#xE9;decine Exp&#xE9;rimentale du Coeur et des Muscles (PhyMedExp), INSERM, CNRS, University of Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Larrieu</surname>
            <given-names>Lise</given-names>
          </name>
          <degrees>M.Sc.</degrees>
          <aff id="A14" xml:lang="fr">Institut Universitaire de Recherche Clinique and Laboratoire de G&#xE9;n&#xE9;tique Mol&#xE9;culaire, University of Montpellier and Centre Hospitalier Universitaire (CHU) de Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schaefer</surname>
            <given-names>Andrew M.</given-names>
          </name>
          <degrees>M.R.C.P.</degrees>
          <aff id="A15">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom; NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alsaif</surname>
            <given-names>Hessa S.</given-names>
          </name>
          <degrees>B.Sc.</degrees>
          <aff id="A16">Departments of Genetics</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alyamani</surname>
            <given-names>Suad</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A17">Neuroscience</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zuchner</surname>
            <given-names>Stephan</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A18">King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; and the Dr. John T. Macdonald Foundation, Department of Human Genetics, and John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>In&#xEA;s A.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A19">Division of Genetics and Molecular Medicine, Guy&#x2019;s Hospital, King&#x2019;s College London School of Medicine, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Deshpande</surname>
            <given-names>Charu</given-names>
          </name>
          <degrees>F.R.C.P.</degrees>
          <aff id="A20">Clinical Genetics Unit, Guy&#x2019;s and St. Thomas&#x2019; NHS Foundation Trust, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pyle</surname>
            <given-names>Angela</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A21">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rauch</surname>
            <given-names>Anita</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A22">Institute of Medical Genetics, University of Zurich, Zurich, Switzerland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Synofzik</surname>
            <given-names>Matthis</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A23">Hertie Institute for Clinical Brain Research and Center of Neurology, and the German Center for Neurodegenerative Diseases, University of T&#xFC;bingen, T&#xFC;bingen, Germany</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkuraya</surname>
            <given-names>Fowzan S.</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A24">Departments of Genetics</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rivier</surname>
            <given-names>Fran&#xE7;ois</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A25">Pediatric Neurology, France; Reference Center for Neuromuscular Diseases Atlantic&#x2013;Occitania&#x2013;Caribbean (AOC), France; CHU de Montpellier, and Laboratoire de Physiologie et M&#xE9;decine Exp&#xE9;rimentale du Coeur et des Muscles (PhyMedExp), INSERM, CNRS, University of Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ryten</surname>
            <given-names>Mina</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A26">Newcastle University, Newcastle Upon Tyne, and the Institute of Child Health, Department of Molecular Neuroscience, University College London Institute of Neurology, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McFarland</surname>
            <given-names>Robert</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A27">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom; NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, London, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Delahodde</surname>
            <given-names>Agn&#xE8;s</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A28">Montpellier, and the Institute for Integrative Biology of the Cell (I2BC), Universit&#xE9; Paris-Saclay, Alternative Energies and Atomic Energy Commission (CEA), CNRS Gif-sur-Yvette, France</aff>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McWilliams</surname>
            <given-names>Thomas G.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A29">Translational Stem Cell Biology and Metabolism Program, Research Programs Unit, and the Department of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koenig</surname>
            <given-names>Michel</given-names>
          </name>
          <degrees>M.D.</degrees>
          <aff id="A30" xml:lang="fr">Institut Universitaire de Recherche Clinique and Laboratoire de G&#xE9;n&#xE9;tique Mol&#xE9;culaire, University of Montpellier and Centre Hospitalier Universitaire (CHU) de Montpellier, France</aff>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Taylor</surname>
            <given-names>Robert W.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <aff id="A31">Wellcome Centre for Mitochondrial Research, London, United Kingdom; Translational and Clinical Research Institute, London, United Kingdom; NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children, London, United Kingdom</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="CR1">Address reprint requests to Dr. Taylor at the Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Newcastle University, Framlington Pl., Newcastle Upon Tyne, NE2 4HH, United Kingdom, or at <email>robert.taylor@ncl.ac.uk</email>.</corresp>
        <fn id="FN1" fn-type="deceased">
          <label>*</label>
          <p id="P1">Deceased.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>20</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>24</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <volume>384</volume>
      <issue>25</issue>
      <fpage>2406</fpage>
      <lpage>2417</lpage>
      <abstract>
        <sec id="S1">
          <title>Background</title>
          <p id="P2">Autophagy is the major intracellular degradation route in mammalian cells. Systemic ablation of core autophagy-related (<italic>ATG</italic>) genes in mice leads to embryonic or perinatal lethality, and conditional models show neurodegeneration. Impaired autophagy has been associated with a range of complex human diseases, yet congenital autophagy disorders are rare.</p>
        </sec>
        <sec id="S2">
          <title>Methods</title>
          <p id="P3">We performed a genetic, clinical, and neuroimaging analysis involving five families. Mechanistic investigations were conducted with the use of patient-derived fibroblasts, skeletal muscle-biopsy specimens, mouse embryonic fibroblasts, and yeast.</p>
        </sec>
        <sec id="S3">
          <title>Results</title>
          <p id="P4">We found deleterious, recessive variants in human <italic>ATG7,</italic> a core autophagy-related gene encoding a protein that is indispensable to classical degradative autophagy. Twelve patients from five families with distinct <italic>ATG7</italic> variants had complex neuro-developmental disorders with brain, muscle, and endocrine involvement. Patients had abnormalities of the cerebellum and corpus callosum and various degrees of facial dysmorphism. These patients have survived with impaired autophagic flux arising from a diminishment or absence of ATG7 protein. Although autophagic sequestration was markedly reduced, evidence of basal autophagy was readily identified in fibroblasts and skeletal muscle with loss of ATG7. Complementation of different model systems by deleterious <italic>ATG7</italic> variants resulted in poor or absent autophagic function as compared with the reintroduction of wild-type <italic>ATG7.</italic>
</p>
        </sec>
        <sec id="S4">
          <title>Conclusions</title>
          <p id="P5">We identified several patients with a neurodevelopmental disorder who have survived with a severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue. (Funded by the Wellcome Centre for Mitochondrial Research and others.)</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>